$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

Re-irradiation for Paediatric Tumours

Clinical oncology : a journal of the Royal College of Radiologists, v.31 no.3, 2019년, pp.191 - 198  

Tsang, D.S. (Radiation Medicine Program, Princess Margaret Cancer Centre, University Health Network) ,  Laperriere, N.J. (Radiation Medicine Program, Princess Margaret Cancer Centre, University Health Network)

Abstract AI-Helper 아이콘AI-Helper

Abstract Despite best available therapy, many children with cancer develop recurrence after multimodal treatment, including initial radiation therapy. Re-irradiation is defined as the use of a second course of radiation therapy with a retreatment volume that overlaps substantially with that of a pr...

주제어

참고문헌 (61)

  1. J Clin Oncol Gajjar 33 2986 2015 10.1200/JCO.2014.59.9217 Pediatric brain tumors: innovative genomic information is transforming the diagnostic and clinical landscape 

  2. Int J Radiat Oncol Biol Phys Jairam 85 e151 2013 10.1016/j.ijrobp.2012.10.007 Historical trends in the use of radiation therapy for pediatric cancers: 1973-2008 

  3. Hall 2012 Radiobiology for the radiologist 

  4. Int J Radiat Oncol Biol Phys Ang 50 1013 2001 10.1016/S0360-3016(01)01599-1 Extent and kinetics of recovery of occult spinal cord injury 

  5. Int J Radiat Oncol Biol Phys Nieder 66 1446 2006 10.1016/j.ijrobp.2006.07.1383 Update of human spinal cord reirradiation tolerance based on additional data from 38 patients 

  6. Lancet Oncol Merchant 10 258 2009 10.1016/S1470-2045(08)70342-5 Conformal radiotherapy after surgery for paediatric ependymoma: a prospective study 

  7. Int J Radiat Oncol Biol Phys Merchant 93 3 S1 2015 10.1016/j.ijrobp.2015.07.009 A phase II trial of conformal radiation therapy for pediatric patients with localized ependymoma, chemotherapy prior to second surgery for incompletely resected ependymoma and observation for completely resected, differentiated, supratentorial ependymoma 

  8. J Clin Oncol Merchant 35 2364 2017 10.1200/JCO.2017.73.1265 Current clinical challenges in childhood ependymoma: a focused review 

  9. Int J Radiat Oncol Biol Phys Merchant 71 87 2008 10.1016/j.ijrobp.2007.09.037 A retrospective study of surgery and reirradiation for recurrent ependymoma 

  10. Int J Radiat Oncol Biol Phys Tsang 100 2 507 2018 10.1016/j.ijrobp.2017.10.002 Outcomes after reirradiation for recurrent pediatric intracranial ependymoma 

  11. SpringerPlus Lobon 5 1 2016 10.1186/s40064-016-2562-1 Re-irradiation of recurrent pediatric ependymoma: modalities and outcomes: a twenty-year survey 

  12. Child's Nerv Syst Zacharoulis 26 905 2010 10.1007/s00381-009-1067-4 Treatment and outcome of children with relapsed ependymoma: a multi-institutional retrospective analysis 

  13. Radiother Oncol Eaton 116 301 2015 10.1016/j.radonc.2015.07.023 Use of proton therapy for re-irradiation in pediatric intracranial ependymoma 

  14. Int J Radiat Oncol Biol Phys Rao 99 634 2017 10.1016/j.ijrobp.2017.07.026 Reirradiation for recurrent pediatric central nervous system malignancies: a multi-institutional review 

  15. Int J Radiat Oncol Biol Phys Bouffet 83 1541 2012 10.1016/j.ijrobp.2011.10.039 Survival benefit for pediatric patients with recurrent ependymoma treated with reirradiation 

  16. BMC Cancer Combs 6 222 2006 10.1186/1471-2407-6-222 Local radiotherapeutic management of ependymomas with fractionated stereotactic radiotherapy (FSRT) 

  17. J Neurosurg Pediatr Kano 6 417 2010 10.3171/2010.8.PEDS10252 Stereotactic radiosurgery for pediatric recurrent intracranial ependymomas 

  18. J Neuro-oncol Hoffman 116 107 2014 Fractionated stereotactic radiosurgery for recurrent ependymoma in children 

  19. Jpn J Radiol Murai 34 211 2016 10.1007/s11604-015-0511-5 Re-irradiation of recurrent anaplastic ependymoma using radiosurgery or fractionated stereotactic radiotherapy 

  20. Pediatr Blood Cancer Liu 52 804 2009 10.1002/pbc.21982 Maximally safe resection followed by hypofractionated re-irradiation for locally recurrent ependymoma in children 

  21. ASCO Meet Abstr Murray 34 10565 2016 Re-irradiation for relapsed paediatric ependymoma 

  22. Neuro Oncol Kondziolka 17 29 2015 10.1093/neuonc/nou284 The biology of radiosurgery and its clinical applications for brain tumors 

  23. Pediatr Blood Cancer Waxweiler 64 2017 10.1002/pbc.26341 Hypofractionated re-irradiation to the brainstem in children with recurrent brain tumors 

  24. J Neuro-Oncol Mansur 66 187 2004 The efficacy of stereotactic radiosurgery in the management of intracranial ependymoma 

  25. Neuro Oncol Cohen 19 1025 2017 10.1093/neuonc/nox021 Diffuse intrinsic pontine gliomas - current management and new biologic insights. Is there a glimmer of hope? 

  26. Acta Neuropathol Louis 131 803 2016 10.1007/s00401-016-1545-1 The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary 

  27. Acta Neuropathol Buczkowicz 128 573 2014 10.1007/s00401-014-1319-6 Histopathological spectrum of paediatric diffuse intrinsic pontine glioma: diagnostic and therapeutic implications 

  28. Pract Radiat Oncol Freese 7 86 2017 10.1016/j.prro.2016.11.005 Radiation and subsequent reirradiation outcomes in the treatment of diffuse intrinsic pontine glioma and a systematic review of the reirradiation literature 

  29. Int J Radiat Oncol Biol Phys Marks 76 S10 2010 10.1016/j.ijrobp.2009.07.1754 Use of normal tissue complication probability models in the clinic 

  30. Eur J Cancer Janssens 73 38 2017 10.1016/j.ejca.2016.12.007 Survival benefit for patients with diffuse intrinsic pontine glioma (DIPG) undergoing re-irradiation at first progression: a matched-cohort analysis on behalf of the SIOP-E-HGG/DIPG working group 

  31. J Neurooncol Carceller 129 109 2016 10.1007/s11060-016-2151-8 Pseudoprogression in children, adolescents and young adults with non-brainstem high grade glioma and diffuse intrinsic pontine glioma 

  32. Anaesthesia Ho 68 126 2013 10.1111/anae.12120 Understanding immortal time bias in observational cohort studies 

  33. J Natl Cancer Inst Heemskerk-Gerritsen 107 djv033 2015 10.1093/jnci/djv033 Breast cancer risk after salpingo-oophorectomy in healthy BRCA1/2 mutation carriers: revisiting the evidence for risk reduction 

  34. Pediatr Blood Cancer Lassaletta 65 6 2018 10.1002/pbc.26988 Reirradiation in patients with diffuse intrinsic pontine gliomas: the Canadian experience 

  35. J Neurooncol Lobon-Iglesias 137 111 2018 10.1007/s11060-017-2702-7 Diffuse intrinsic pontine gliomas (DIPG) at recurrence: is there a window to test new therapies in some patients? 

  36. J Neurooncol Massimino 118 305 2014 Results of nimotuzumab and vinorelbine, radiation and re-irradiation for diffuse pontine glioma in childhood 

  37. Am J Clin Oncol Fontanilla 35 51 2012 10.1097/COC.0b013e318201a2b7 Palliative reirradiation for progressive diffuse intrinsic pontine glioma 

  38. Neuro Oncol Jakacki 18 1442 2016 10.1093/neuonc/now038 Phase 2 study of concurrent radiotherapy and temozolomide followed by temozolomide and lomustine in the treatment of children with high-grade glioma: a report of the Children's Oncology Group ACNS0423 study 

  39. J Neurooncol Kline 137 103 2018 10.1007/s11060-017-2701-8 Survival outcomes in pediatric recurrent high-grade glioma: results of a 20-year systematic review and meta-analysis 

  40. Clin Oncol Ho 30 124 2018 10.1016/j.clon.2017.11.006 Re-irradiation in the brain: primary gliomas 

  41. Radiat Oncol Muller 9 177 2014 10.1186/1748-717X-9-177 Reirradiation as part of a salvage treatment approach for progressive non-pontine pediatric high-grade gliomas: preliminary experiences from the German HIT-HGG study group 

  42. Clin Oncol Ho 30 457 2018 10.1016/j.clon.2018.03.008 Glioma re-irradiation and neurocognitive dysfunction 

  43. Neuro Oncol Packer 15 97 2013 10.1093/neuonc/nos267 Survival and secondary tumors in children with medulloblastoma receiving radiotherapy and adjuvant chemotherapy: results of Children's Oncology Group trial A9961 

  44. Lancet Oncol Gajjar 7 813 2006 10.1016/S1470-2045(06)70867-1 Risk-adapted craniospinal radiotherapy followed by high-dose chemotherapy and stem-cell rescue in children with newly diagnosed medulloblastoma (St Jude Medulloblastoma-96): long-term results from a prospective, multicentre trial 

  45. Lancet Oncol Thompson 17 484 2016 10.1016/S1470-2045(15)00581-1 Prognostic value of medulloblastoma extent of resection after accounting for molecular subgroup: a retrospective integrated clinical and molecular analysis 

  46. 10.1016/j.ijrobp.2016.09.046 Michalski JM, Janss A, Vezina G, Gajjar A, Pollack I, Merchant TE et al. Results of COG ACNS0331: a phase III trial of involved-field radiotherapy (IFRT) and low dose craniospinal irradiation (LD-CSI) with chemotherapy in average-risk medulloblastoma: a report from the Children's Oncology Group. Int J Radiat Oncol Biol Phys 2016;96:937-938. https://doi.org/10.1016/j.ijrobp.2016.09.046 

  47. Cancer Wetmore 120 3731 2014 10.1002/cncr.28907 Reirradiation of recurrent medulloblastoma: does clinical benefit outweigh risk for toxicity? 

  48. J Neurooncol Milker-Zabel 60 227 2002 10.1023/A:1021184400053 Results of three-dimensional stereotactically-guided radiotherapy in recurrent medulloblastoma 

  49. Cancer Bakst 117 4977 2011 10.1002/cncr.26148 Reirradiation for recurrent medulloblastoma 

  50. Pediatr Blood Cancer Saran 50 554 2008 10.1002/pbc.21382 Hypofractionated stereotactic radiotherapy in the management of recurrent or residual medulloblastoma/PNET 

  51. Neuro Oncol Gururangan 10 745 2008 10.1215/15228517-2008-044 Efficacy of high-dose chemotherapy or standard salvage therapy in patients with recurrent medulloblastoma 

  52. Technol Cancer Res Treat Gultekin 16 195 2017 10.1177/1533034616655952 Reirradiation of pediatric tumors using hypofractionated stereotactic radiotherapy 

  53. Rep Pract Oncol Radiother Chojnacka 17 32 2012 10.1016/j.rpor.2011.10.004 Reirradiation of relapsed brain tumors in children 

  54. J Neurooncol Wang 137 77 2018 10.1007/s11060-017-2696-1 Practice patterns and survival outcomes of intracranial germinoma: an analysis of the National Cancer Database 

  55. J Neurooncol Cheng 127 173 2016 10.1007/s11060-015-2029-1 Outcomes of children with central nervous system germinoma treated with multi-agent chemotherapy followed by reduced radiation 

  56. Neuro Oncol Calaminus 15 788 2013 10.1093/neuonc/not019 

  57. J Neurooncol Kamoshima 90 205 2008 10.1007/s11060-008-9649-7 Late recurrence and salvage therapy of CNS germinomas 

  58. Int J Radiat Oncol Biol Phys Hu 84 639 2012 10.1016/j.ijrobp.2011.12.052 Salvage treatment for recurrent intracranial germinoma after reduced-volume radiotherapy: a single-institution experience and review of the literature 

  59. Halperin 2012 Pediatric radiation oncology 

  60. Pediatr Blood Cancer Taunk 63 731 2016 10.1002/pbc.25863 Short-interval retreatment with stereotactic body radiotherapy (SBRT) for pediatric neuroblastoma resulting in severe myositis 

  61. Sarcoma Brown 2014 418270 2014 10.1155/2014/418270 Stereotactic body radiotherapy for metastatic and recurrent Ewing sarcoma and osteosarcoma 

관련 콘텐츠

저작권 관리 안내
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로